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ABSTRACT 
An unusually high number of positive adenovirus stool antigen tests were observed in neonatal samples 
from a large tertiary referral unit over a 10-week period, prompting the declaration of an outbreak and 
escalation of infection control precautions accordingly. Subsequent testing of original samples by 
alternative methods revealed a series of false-positive results. This is the first adenovirus pseudo-
outbreak to be reported in the United Kingdom, and the first using the Proflow™ Rotavirus-Adenovirus 
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ABSTRACT 
An unusually high number of positive adenovirus stool antigen tests were observed in neonatal samples 
from a large tertiary referral unit over a 10-week period, prompting the declaration of an outbreak and 
escalation of infection control precautions accordingly. Subsequent testing of original samples by 
alternative methods revealed a series of false-positive results. This is the first adenovirus pseudo-
outbreak to be reported in the United Kingdom, and the first using the Proflow™ Rotavirus-Adenovirus 
Combi test.  
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BACKGROUND 
Adenovirus infection is a common cause of gastroenteritis in children, making it an important 
consideration in the diagnostic processing of paediatric diarrhoeal stool specimens1.  Adenoviruses may 
be shed for months after initial infection2, 3, are highly resistant to physical and chemical cleaning4, and 
remain stable at room temperature for prolonged periods in fomites4, making them a particular 
infection control challenge. While enteric infection rarely causes systemic disease in the 
immunocompetent, neonates and the immunocompromised can develop disseminated infection, which 
carries high risk of morbidity and mortality4, 5, 6. 
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The Proflow™ Rotavirus-Adenovirus Combi test is a single-use rapid membrane immunoassay for the 
qualitative detection of rotavirus and adenovirus antigens in faeces. The manufacturers report both 
sensitivity and specificity of >99% when compared to results of another commercially available 
adenovirus antigen immunochromatographic membrane assay7, but no comparisons with alternative 
testing methods are available. There is also reportedly no known cross-reactivity to astrovirus, 
Escherichia coli, Campylobacter spp., Giardia lamblia, or human haemaglobin7.  
 
From 31st July to 8th October 2017, 12 stool specimens from 6 neonatal intensive care patients tested 
positive for adenovirus antigen, prompting the declaration of an outbreak. Here, we describe the 
process of discovery of a pseudo-outbreak due to a series of false-positive results, and how a look-back 
through previously reported results revealed a much larger-scale problem. Neonatal pseudo-outbreaks 
of adenovirus and rotavirus have previously been reported8,9, but this is the first UK adenovirus pseudo-
outbreak, and the first arising from the Proflow™ Rotavirus-Adenovirus Combi.  
 
MATERIALS AND METHODS 
Hospital setting 
Addenbrooke’s Hospital is a 1000-bedded teaching hospital in the East of England that serves a large 
geographical area.  The Neonatal Intensive Care Unit has capacity for 40 critically ill patients and 
frequently cares for neonates with complex medical and surgical needs, and those born at <28 weeks 
gestation.  
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Antigen testing 
Adenovirus antigen testing was performed using the Proflow™ Rotavirus-Adenovirus Combi test, in 
accordance with manufacturer’s instructions7. Kit-provided negative and positive controls were run with 
each batch of tests, with no control failure identified. Stool samples were collected in universal 
containers and tested within 12 hours of sample receipt. 
 
Polymerase chain reaction (PCR) 
Adenovirus PCR was performed using an in-house assay that targets a pan-specific region of the hexon 
gene, with a lower limit of detection of 2 copies/ml (95% CL 1.6-4.3) using adenovirus type 2 DNA (Cat. 
No. 15270-010; Life Technologies). The assay has long been in routine use for blood, respiratory, and 
cerebrospinal fluid samples, and was validated for stool specimens by comparing serial log dilutions of a 
high concentration of adenovirus in phosphate-buffered saline and 10% faecal suspension. This 
demonstrated a linear relationship between cycle threshold value and log dilution (R2 value of 0.984). 
DNA extraction was performed using QIAGEN’s QIAsymphony® DSP virus/pathogen mini extraction kit, 
following a mechanical bead-beating step. Positive and negative controls were included in each run, as 
was a pre-extraction internal control for identifying incomplete DNA extraction and inhibitors of 
amplification. 
 
Clinical and test data extraction 
Suspected outbreak results were collated prospectively. Clinical data and historical testing data were 
extracted using the hospital’s electronic health records system. 
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RESULTS 
Concerns of an adenovirus outbreak arose on 9th September 2017, following five positive antigen tests 
from three patients in shared clinical areas. Enhanced infection control measures, including 
departmental deep cleaning and the use of gloves and aprons for routine care, were implemented from 
11th September. Between then and 13th October, a further two samples from these patients, plus five 
samples from three additional patients, tested positive (figure 1). This triggered further deep cleaning, 
and screening of asymptomatic contacts. Table 1 shows the clinical characteristics of suspected 
outbreak cases, all of whom were born preterm with low, very low, or extremely low birth weight. For 
each of the symptomatic neonates, common enteric bacterial pathogens were excluded by routine stool 
culture on xylose-lysine-deoxycholate (XLD), cefixime-tellurite-sorbitol-MacConkey (CT-SMAC), and 
charcoal-cefoperazone-deoxycholate (CCDA) agars. Staining for cryptosporidium was also performed as 
a matter of routine. In view of the emergence of new cases of detectable adenovirus antigen despite 
escalated infection control precautions, a pseudo-outbreak was suspected. Eleven of 12 positive 
samples from the six ‘outbreak’ cases, and 13 of 14 positive screening samples from 29 asymptomatic 
contacts, were retrieved from storage for re-testing. Sixteen of these samples underwent repeat 
Rotavirus-Adenovirus Combi testing, which gave 81.3% agreement with the initial results (13/16). 
However, none of the 24 samples that were re-tested by PCR gave a positive result. In light of this, the 
situation was revised to that of a pseudo-outbreak on 19th October and standard infection control 
practices resumed. 
 
Norovirus infection was retrospectively excluded by validated in-house PCR on one original stool sample 
from each of the symptomatic neonates. The five neonates for which there was sufficient stool sample 
remaining were retrospectively tested for rotavirus at the national reference laboratory. Rotavirus PCR 
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revealed one case of detectable rotavirus that was characterised as wild-type in one of two confirmation 
assays (Patient E), and one case of detectable vaccine-strain rotavirus in a neonate that had received 
ROTARIX vaccination ten days prior to sample collection (Patient F). Other common bacterial, parasitic, 
and viral causes of gastroenteritis were excluded by a twenty five pathogen TaqMan Array Card (Applied 
Biosystems, Foster City, CA) assay, using stored nucleic acid from each original stool sample. It must be 
acknowledged, however, that this assay is not yet validated for clinical use. 
 
Re-evaluation of past tests 
A look back exercise of all adenovirus antigen tests performed between 1st August and 19th October 
2017 revealed that of 643 samples tested, 204 (31.7%) had been reported positive. These involved tests 
from two separate Proflow™ Rotavirus-Adenovirus Combi kits. Seventy-six of the 204 samples reported 
positive were recovered from storage for re-testing with PCR. Of these, 12 (15.8%) were positive, 62 
(81.6%) were negative, and two (2.6%) gave invalid results due to internal control failure. The Medicines 
and Healthcare products Regulatory Agency (MHRA) were informed of these investigation findings, and 
the Proflow™ Rotavirus-Adenovirus Combi test was subsequently withdrawn from sale in the United 
Kingdom and replaced by the Proflow™ Rotavirus-Adenovirus Dual Test. This replacement product, 
which has a modified display for presenting positive results, uses identical antibodies, diluent, and test 
method to the Rotavirus-Adenovirus Combi. In response to this pseudo-outbreak investigation, our 
laboratory has adjusted its algorithm for the routine detection of adenovirus in stool to include the use 
of in-house PCR. 
 
 
Table 1. Clinical characteristics of pseudo-outbreak cases 
Characteristic Patient A Patient B Patient C Patient D Patient E Patient F 
Chronological age 
(days) 
 
14 39 12 33 31 74 
Gestational age 
(weeks + days) 
 
23+5 34+1 26+5 31+0 24+1 31+2 
Sex 
 
M F F M M M 
Birth weight 
(grams) 
 
665 2050 930 1200 391 1730 
Description of 
stool 
 
Watery Loose 
 
Light brown 
Offensive  
 
Yellow 
Watery Watery Watery 
Number of 
positive antigen 
tests 
 
2 3 2 1 1 3 
Concurrent 
infections 
 
Staphylococcus 
haemolyticus 
 
Nil Staphylococcus 
aureus 
 
Nil Serratia 
marcescens 
 
Staphylococcus 
aureus 
 
Rhinovirus 
 
Co-morbidity at 
the time of first 
positive 
Sepsis 
 
RDS* 
 
PDA† 
 
Anaemia 
Oesophageal 
atresia 
 
Gastrostomy 
 
Dextrocardia 
 
Absent right 
lung 
Sepsis 
 
Jaundice 
 
Metabolic 
acidosis 
Sepsis 
 
RDS* 
 
Jaundice 
Sepsis 
 
RDS* 
 
PDA† 
 
Dysplastic 
aortic valve 
 
Jaundice 
 
Necrosis of 
small toe 
 
RDS* 
 
Bilateral 
congenital 
talipes 
equinovarus 
deformity 
* RDS = Respiratory Distress Syndrome  † PDA = Patent Ductus Arteriosus 
 
CONCLUSIONS 
The cause of assay false-reactivity that led to this pseudo-outbreak remains unclear; exhaustive 
investigation of the underlying mechanism of test failure is beyond the scope of this report, but should 
be undertaken by Pro-Lab Diagnostics, in liaison with the MHRA. There are inherent differences in the 
constituents of neonatal and adult stools, arising from dietary and environmental factors, as well as 
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differences in the microbiome10. These differences could provide potential explanations for the higher 
false-positivity rate among this cohort of neonatal patients (100%) compared to the overall false-
positivity rate of all samples included in the look back exercise (81.6%). While likely alternative causes of 
infective gastroenteritis were excluded by routine and experimental methods for each of these 
suspected outbreak patients, potential extraintestinal and non-infective explanations for their loose 
stools remain. The 2009 National Institute for Health and Care Excellence (NICE) Diarrhoea and Vomiting 
Caused by Gastroenteritis: Diagnosis, Assessment and Management in Children Younger than 5 Years 
guidelines (Clinical Guideline: CG84) highlight non-enteric infections, surgical or inflammatory bowel 
conditions, and drug-induced diarrhoea as important considerations in patients presenting with loose 
stools11. They also state that “Children younger than 12–18 months commonly present with non-specific 
symptoms and signs of non-enteric infections and non-infective gastrointestinal disorders”. All of the 
patients involved in this pseudo-outbreak were on broad spectrum antibiotic therapy, which could 
account for their altered bowel habit. Additional potential causes of diarrhoea can be identified as 
follows: Patient A had sepsis; Patient B had a functioning gastrostomy in situ; Patient C had sepsis and 
jaundice; Patient D had sepsis and jaundice; Patient E had sepsis and jaundice (Table 1). 
 
This pseudo-outbreak serves as a stark reminder of the need for caution when interpreting a high 
incidence of positive results from a microbiological test. In this instance, the mislabelling of false-
positive results as an infectious outbreak led to significant cost through unnecessary infection control 
measures and repeat testing of samples, as well as damage to the reputation of the laboratory and 
hospital, and avoidable anxiety for the relatives of neonates wrongly labelled as infected. Future clusters 
of results suspicious for false-positivity should be scrutinised by alternative testing methods at the 
earliest possible opportunity. 
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